Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

A call for next generation of professors: Apply for the Vice-Chancellor’s Prestige Scholars’ Programme
2014-12-19

 

Examples of the rector's prestige scholars' international footprint: Dr Olihile Sebolai, Fulbright scholar (left) returned to the UFS after six months at the University of Birmingham and three at the University of Missouri. Dr Cilliers van den Berg (right) visited Cornell University on a ten-month sabbatical.

The Vice-Chancellor’s Prestige Scholars’ Programme (PSP) seeks to identify, develop and promote the next cohort of the most promising and talented UFS academic members of staff who obtained a doctoral degree within the last five years or will graduate by June 2015.

Scholars identified benefit from an intensive programme of academic and professional support that includes an advanced residential programme, exposure to leading scholars, concentrated reading and writing programmes, high-level seminar participation and presentation, nuanced publication schedules and personal mentoring and advice, including participation in the annual PSP mock NRF rating and the development of a postdoctoral intellectual project for funding submission (Thuthuka, and similar).

Past prestige scholars have become Fulbright scholars, received funding from among others the Association of Commonwealth Universities, the Japan Society for the Promotion of Science, Erasmus Mundus, NRF Blue Skies, Thuthuka, etc. They have spent time at universities in Canada, the USA, United Kingdom, Europe and Japan.

This year the selection process will be anticipated by pre-selection. Final selection to the programme will take place in September 2015. The selection is highly competitive, and aimed at those young scholars with the potential to obtain upper-level NRF ratings (Y1 and P).

Criteria for selection:

Recently obtained a PhD degree. 
Evidence of an active publication record. 
Early recognition of scholarly work, e.g. successful funding/grant applications and academic awards. 
The early development of a post-doctoral intellectual project that shows evidence of scholarly “potential” (defined by the NRF Y-category). 
Indication of the young scholar’s understanding of what their envisaged postdoctoral endeavours will contribute to the body of disciplinary knowledge. 
Full participation in the pre-selection residential programme and activities is a requirement for selection.

Call for interest: 2015 (PDF)

Requests for further information can be directed to Prof Jackie du Toit at dutoitjs@ufs.ac.za.

Applications close on 16 February 2015.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept